SCHEMBL5685358

SCHEMBL5685358

O=c1[nH]c(=O)c2[nH]c(CCCc3cnn(Cc4cc(C(F)(F)F)ccc4Cl)c3)nc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 13/20 0.45
ADORA2A P29274 6/20 0.45
ADORA1 P30542 5/20 0.45
ADORA3 P0DMS8 4/20 0.45
TRAP1 Q12931 3/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90B1 P14625 1/20 0.40
LMNA P02545 2/20 0.33
PKM P14618 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2B6 P20813 1/20 0.32
CYP2C19 P33261 1/20 0.32
TEC P42680 1/20 0.32
TXK P42681 1/20 0.32
BMX P51813 1/20 0.32
BTK Q06187 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4013561 0.89 ADORA2B (0.42) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL4320462 0.78 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3
SCHEMBL5608377 0.72 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3
SCHEMBL5685510 0.71 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3
SCHEMBL1720832 0.67 ADORA2B (0.37) ADORA2BMEN1KMT2A
SCHEMBL30012217 0.67 ADORA2B (0.71) ADORA2BADORA2AADORA1ADORA3
SCHEMBL1945569 0.65 ADORA2B (0.78) ADORA2BADORA2AADORA1ADORA3
SCHEMBL1945936 0.62 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3
SCHEMBL15642930 0.61 HCAR2 (0.43) ADORA2BADORA2AADORA1ADORA3
SCHEMBL18996851 0.60 FFAR1 (0.47) ADORA2BADORA2AADORA1ADORA3TRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1622908-A1 XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-02-08 EP disclosed
WO-2004106337-A1 XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2004-12-09 WO disclosed